A different detection method reveals a new role of alanine aminotransferase as an indicator of liver fibrosis.
作者信息
Sung Pil Soo
机构信息
Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Korea.
出版信息
Korean J Intern Med. 2020 Mar;35(2):295-297. doi: 10.3904/kjim.2020.050. Epub 2020 Feb 28.
Abstract
摘要
相似文献
1
A different detection method reveals a new role of alanine aminotransferase as an indicator of liver fibrosis.一种不同的检测方法揭示了丙氨酸转氨酶作为肝纤维化指标的新作用。
Korean J Intern Med. 2020 Mar;35(2):295-297. doi: 10.3904/kjim.2020.050. Epub 2020 Feb 28.
2
3
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.在丙型肝炎病毒感染持续正常丙氨酸氨基转移酶患者中，FIB-4、天门冬氨酸氨基转移酶与血小板比值指数和肝硬度测量的诊断价值。
World J Gastroenterol. 2017 Aug 21;23(31):5746-5754. doi: 10.3748/wjg.v23.i31.5746.
4
5
SERUM ASPARTATE AND ALANINE TRANSAMINASE LEVELS IN WORKERS EXPOSED TO LEAD.接触铅的工人的血清天冬氨酸和丙氨酸转氨酶水平
J Clin Pathol. 1964 Mar;17(2):149. doi: 10.1136/jcp.17.2.149.
6
[Transaminase activity of the liver in hepatic patients].[肝病患者肝脏的转氨酶活性]
Boll Soc Ital Biol Sper. 1963 Feb 15;39:136-8.
7
[GLUTAMATE-ASPARTATE AND GLUTAMATE-ALANINE TRANSAMINASE ACTIVITY IN TISSUES OF DEVELOPING EMBRYOS].[发育中胚胎组织中的谷氨酸-天冬氨酸转氨酶和谷氨酸-丙氨酸转氨酶活性]
Biokhimiia. 1964 Mar-Apr;29:185-90.
8
[Alterations in serum transaminase activities in viral hepatitis and liver cirrhosis. II. Effect of adrenocortical steroid hormone on the activities].[病毒性肝炎和肝硬化时血清转氨酶活性的改变。II. 肾上腺皮质类固醇激素对活性的影响]
Jpn J Med Sci Biol. 1962 Jun 10;51:227-36. doi: 10.2169/naika.51.227.
9
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.在慢性丙型肝炎患者中，基于四个因素的纤维化指数比天冬氨酸转氨酶/血小板比率指数能更好地预测进展性肝纤维化或肝硬化。
J Formos Med Assoc. 2015 Oct;114(10):923-8. doi: 10.1016/j.jfma.2015.07.004. Epub 2015 Aug 13.
10
Predictive value of aspartate aminotransferase to alanine aminotransferase ratio for hepatic fibrosis and clinical adverse outcomes in patients with primary biliary cirrhosis.天门冬氨酸氨基转移酶与丙氨酸氨基转移酶比值对原发性胆汁性肝硬化患者肝纤维化和临床不良结局的预测价值。
J Clin Gastroenterol. 2009 Oct;43(9):876-83. doi: 10.1097/MCG.0b013e31818980ac.
引用本文的文献
1
Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States.ALT/AST 比值升高作为非酒精性脂肪性肝病风险和严重程度的标志物：来自美国横断面分析的见解。
Front Endocrinol (Lausanne). 2024 Aug 26;15:1457598. doi: 10.3389/fendo.2024.1457598. eCollection 2024.
2
Clinical characteristics and changes in serum CXCL10 and CXCL16 levels in patients with severe mycoplasma pneumonia.严重肺炎支原体肺炎患者的临床特征及血清 CXCL10 和 CXCL16 水平的变化。
Medicine (Baltimore). 2024 Apr 19;103(16):e37814. doi: 10.1097/MD.0000000000037814.
3
Hepatoprotective effect of nanoniosome loaded Myristica fragrans phenolic compounds in mice-induced hepatotoxicity.纳米囊泡载肉豆蔻酚类化合物对小鼠肝毒性的保护作用。
J Cell Mol Med. 2022 Nov;26(21):5517-5527. doi: 10.1111/jcmm.17581. Epub 2022 Oct 12.
本文引用的文献
1
Recent advances in the non-invasive assessment of fibrosis using biomarkers.使用生物标志物进行纤维化无创评估的最新进展。
Curr Opin Pharmacol. 2019 Dec;49:110-115. doi: 10.1016/j.coph.2019.09.010. Epub 2019 Nov 19.
2
Adaptive immunity: an emerging player in the progression of NAFLD.适应性免疫：非酒精性脂肪性肝病进展中的新兴参与者。
Nat Rev Gastroenterol Hepatol. 2020 Feb;17(2):81-92. doi: 10.1038/s41575-019-0210-2. Epub 2019 Oct 11.
3
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials.非侵入性检测准确识别 NASH 所致的晚期纤维化：来自 STELLAR 试验的基线数据。
Hepatology. 2019 Nov;70(5):1521-1530. doi: 10.1002/hep.30842. Epub 2019 Aug 19.
4
The Differential Roles of T Cells in Non-alcoholic Fatty Liver Disease and Obesity.T 细胞在非酒精性脂肪性肝病和肥胖中的差异作用。
Front Immunol. 2019 Feb 6;10:82. doi: 10.3389/fimmu.2019.00082. eCollection 2019.
5
Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation.天门冬氨酸/丙氨酸氨基转移酶的免疫学测定在预测肝纤维化和炎症中的作用。
Korean J Intern Med. 2020 Mar;35(2):320-330. doi: 10.3904/kjim.2018.214. Epub 2019 Jan 23.
6
Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases.慢性乙型肝炎病毒感染患者肝功能正常时肝纤维化程度的特征描述和评估。
Clin Mol Hepatol. 2018 Dec;24(4):384-391. doi: 10.3350/cmh.2018.0004. Epub 2018 Jul 4.
7
Histopathological evaluation of liver fibrosis and cirrhosis regression.肝纤维化和肝硬化逆转的组织病理学评估。
Clin Mol Hepatol. 2017 Dec;23(4):302-307. doi: 10.3350/cmh.2017.0078. Epub 2017 Dec 20.
8
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis.欧洲肝脏研究学会-阿莱赫临床实践指南：用于评估肝脏疾病严重程度和预后的非侵入性检查
J Hepatol. 2015 Jul;63(1):237-64. doi: 10.1016/j.jhep.2015.04.006. Epub 2015 Apr 21.
9
Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.肝脏酶、代谢组学与全基因组关联研究：从系统生物学走向个性化医疗
World J Gastroenterol. 2015 Jan 21;21(3):711-25. doi: 10.3748/wjg.v21.i3.711.
10
Analysis of the enzymatic properties of a broad family of alanine aminotransferases.分析一大类丙氨酸氨基转移酶的酶学特性。
PLoS One. 2013;8(2):e55032. doi: 10.1371/journal.pone.0055032. Epub 2013 Feb 7.
Zotero 插件